What is the latest selling price of lorlatinib in the Chinese market?

Lorlatinib is a third-generation ALKtyrosine kinase inhibitor (TKI), used to treat ALK positive non-small cell lung cancer, especially for patients who are resistant to first- and second-generation TKI treatments. In recent years, as the drug has been officially launched in mainland China and included in medical insurance, more and more patients can obtain treatment through formal channels. However, because drug pricing and medical insurance policies vary from place to place, the price of lorlatinib is still a common focus among patients.

In mainland China, lorlatinib has been approved for marketing by the State Food and Drug Administration and included in the National Basic Medical Insurance Drug Catalog. Patients can purchase it at some tertiary hospital pharmacies or DTP pharmacies with a doctor's prescription. Before reimbursement by medical insurance, the price of each box (usually 100mg×30 tablets) is approximately between one and twenty thousand yuan. The reimbursement ratio of medical insurance varies according to different regional policies. In some areas, the out-of-pocket expenses after reimbursement can be as low as several thousand yuan. It is recommended that patients go to the medical insurance department of their city or the designated hospital pharmacy for detailed consultation.

In overseas markets, lorlatinib is also available in multiple versions. Among them, the relatively cheap ones are Turkish original drugs, which cost about 7,000 yuan per box. The quality of the drugs is basically the same as that of domestic original drugs. The original drugs sold in Hong Kong, China, are more expensive, about 3 RMB per box, and are mainly targeted at patients who are not covered by medical insurance or who need to obtain drugs quickly. Some cross-border medical platforms can provide purchasing services, but attention must be paid to channel formality and transportation compliance.

For patients with limited budgets, overseas generic versions may also be considered. For example, the price of generic drugs from Laos or Bangladesh is only about 1,000 yuan. Although the chemical composition and bioavailability are consistent with the original drugs, there are slight differences in production supervision standards and dissolution stability. The use of generic drugs should be done with the knowledge of a doctor and closely monitored for efficacy and adverse reactions. Generally speaking, the price of lorlatinib varies greatly around the world. Patients should reasonably choose drug purchase channels and medication plans based on their own condition and economic status.

Reference materials:https://www.drugs.com/